These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28157234)

  • 1. The citrus flavanone naringenin impairs dengue virus replication in human cells.
    Frabasile S; Koishi AC; Kuczera D; Silveira GF; Verri WA; Duarte Dos Santos CN; Bordignon J
    Sci Rep; 2017 Feb; 7():41864. PubMed ID: 28157234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus.
    Cataneo AHD; Kuczera D; Koishi AC; Zanluca C; Silveira GF; Arruda TB; Suzukawa AA; Bortot LO; Dias-Baruffi M; Verri WA; Robert AW; Stimamiglio MA; Duarte Dos Santos CN; Wowk PF; Bordignon J
    Sci Rep; 2019 Nov; 9(1):16348. PubMed ID: 31705028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-Zika virus and anti-tumoral activity of the citrus flavanone lipophilic naringenin-based compounds.
    Albuquerque de Oliveira Mendes L; Ponciano CS; Depieri Cataneo AH; Wowk PF; Bordignon J; Silva H; Vieira de Almeida M; Ávila EP
    Chem Biol Interact; 2020 Nov; 331():109218. PubMed ID: 32916141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinic acid derivatives inhibit dengue virus replication in vitro.
    Zanello PR; Koishi AC; Rezende Júnior Cde O; Oliveira LA; Pereira AA; de Almeida MV; Duarte dos Santos CN; Bordignon J
    Virol J; 2015 Dec; 12():223. PubMed ID: 26695767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
    Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
    Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
    Sze A; Olagnier D; Hadj SB; Han X; Tian XH; Xu HT; Yang L; Shi Q; Wang P; Wainberg MA; Wu JH; Lin R
    Viruses; 2017 Oct; 9(10):. PubMed ID: 28972551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.
    Raut R; Beesetti H; Tyagi P; Khanna I; Jain SK; Jeankumar VU; Yogeeswari P; Sriram D; Swaminathan S
    Virol J; 2015 Feb; 12():16. PubMed ID: 25886260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of silymarin and baicalein against dengue virus.
    Low ZX; OuYong BM; Hassandarvish P; Poh CL; Ramanathan B
    Sci Rep; 2021 Oct; 11(1):21221. PubMed ID: 34707245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.
    Smith JL; Stein DA; Shum D; Fischer MA; Radu C; Bhinder B; Djaballah H; Nelson JA; Früh K; Hirsch AJ
    J Virol; 2014 May; 88(10):5533-42. PubMed ID: 24599995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.
    Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R
    Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extract of Scutellaria baicalensis inhibits dengue virus replication.
    Zandi K; Lim TH; Rahim NA; Shu MH; Teoh BT; Sam SS; Danlami MB; Tan KK; Abubakar S
    BMC Complement Altern Med; 2013 Apr; 13():91. PubMed ID: 23627436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
    Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
    Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
    Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
    Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antiviral activity of baicalein against dengue virus.
    Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
    BMC Complement Altern Med; 2012 Nov; 12():214. PubMed ID: 23140177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication.
    Hishiki T; Kato F; Nio Y; Watanabe S; Wen Tan NW; Yamane D; Miyazaki Y; Lin CC; Suzuki R; Tajima S; Lim CK; Saijo M; Hijikata M; Vasudevan SG; Takasaki T
    Antiviral Res; 2019 May; 165():42-46. PubMed ID: 30853381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms.
    Kato F; Hishiki T
    Viruses; 2016 May; 8(5):. PubMed ID: 27164125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antiviral activity of bromocriptine against dengue virus replication.
    Kato F; Ishida Y; Oishi S; Fujii N; Watanabe S; Vasudevan SG; Tajima S; Takasaki T; Suzuki Y; Ichiyama K; Yamamoto N; Yoshii K; Takashima I; Kobayashi T; Miura T; Igarashi T; Hishiki T
    Antiviral Res; 2016 Jul; 131():141-7. PubMed ID: 27181378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of lanatoside C against dengue virus infection.
    Cheung YY; Chen KC; Chen H; Seng EK; Chu JJ
    Antiviral Res; 2014 Nov; 111():93-9. PubMed ID: 25251726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.